Related Experiment Video

Updated: Aug 30, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Influence of cyclosporin A (CyA) on renal handling of urate

R Marcén1, N Gallego, L Orofino

  • 1Department of Nephrology, Hospital Ramón y Cajal, Madrid, Spain.

Transplant International : Official Journal of the European Society for Organ Transplantation
|January 1, 1992
PubMed

Insights

Cyclosporin A (CyA) therapy in renal transplant patients frequently causes hyperuricaemia. This study investigated risk factors and mechanisms, using a combined pyrazinamide and probenecid test to better understand urate transport.

Area of Science:

  • Nephrology
  • Pharmacology
  • Metabolic Disorders

Background:

  • Hyperuricaemia is a common adverse effect of Cyclosporin A (CyA) treatment in renal transplant recipients.
  • Gout arthritis leads to significant morbidity in these patients.
  • The predisposing factors and mechanisms of CyA-induced hyperuricaemia remain unclear.

Purpose of the Study:

  • To determine the prevalence of hyperuricaemia in renal transplant patients undergoing CyA therapy.
  • To identify potential risk factors associated with hyperuricaemia in this population.
  • To elucidate the underlying mechanisms of hyperuricaemia by evaluating renal urate handling.

Main Methods:

  • Retrospective analysis of renal transplant patients.
  • Assessment of hyperuricaemia prevalence and associated risk factors.
  • Utilisation of a combined pyrazinamide and probenecid test to evaluate urate transport processes in the renal tubules.

Main Results:

  • The study population exhibited a notable prevalence of hyperuricaemia.
  • Specific risk factors contributing to hyperuricaemia were identified.
  • The pyrazinamide and probenecid test provided enhanced insights into renal urate handling mechanisms compared to previous methods.

Conclusions:

  • Hyperuricaemia is a significant clinical issue in renal transplant patients on CyA.
  • Understanding risk factors and mechanisms is crucial for managing hyperuricaemia and preventing gout.
  • Advanced testing methods offer improved evaluation of renal urate transport in CyA-treated patients.

More Related Videos

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted less...